DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
DSGN Design Therapeutics
- 4.080
- +0.110+2.77%
Close Feb 14 16:00 ET
- 4.080
- 0.0000.00%
Post 20:01 ET
231.01MMarket Cap-4.80P/E (TTM)
4.190High3.905Low135.12KVolume3.990Open3.970Pre Close554.20KTurnover0.54%Turnover RatioLossP/E (Static)56.62MShares7.77052wk High0.92P/B102.98MFloat Cap2.45052wk Low--Dividend TTM25.24MShs Float50.500Historical High--Div YieldTTM7.18%Amplitude1.940Historical Low4.101Avg Price1Lot Size
About Design Therapeutics Company
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Company Profile
SymbolDSGN
Company NameDesign Therapeutics
Listing DateMar 26, 2021
Issue Price20.00
Founded2017
CEODr. Pratik Shah, PhD
MarketNASDAQ
Employees124
Fiscal Year Ends12-31
Address6005 Hidden Valley Road,Suite 110
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92011
Phone1-858-293-4900
Websitehttp://www.designtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Pratik Shah, PhD
- Chairperson of the Board, President, Chief Executive Officer and Principal Financial Officer
- 6.32M
- Julie Burgess
- Chief Accounting Officer
- --
- Dr. Sean Jeffries, PhD
- Chief Operating Officer
- 1.28M
- Dr. Jae B. Kim, M.D.
- Chief Medical Officer
- --
- Dr. Heather Berger, PhD
- Independent Director
- 94.20K
- Dr. Arsani William, M.D.
- Independent Director
- 104.20K
- Deepa Prasad
- Independent Director
- 94.20K
- Dr. Simeon J. George, M.B.A.,M.D.
- Lead Independent Director
- 95.70K
- Dr. Rodney W. Lappe, PhD
- Independent Director
- 228.56K
- Dr. Stella Xu, PhD
- Independent Director
- 94.20K
- John P. Schmid
- Independent Director
- 106.70K